Updated time: 2023-12-05 15:14:48
12A-1060111
TW I659751、US 11,382,983B2
The invention describes an intracranial drug delivery system, capable of capturing and retaining selected anti-cancer drugs at a specified site. The anti-cancer drugs may be given intravenously, and will circulate to the capture site, bind the antibody, and therefore be retained. This accumulated retention allows the anti-cancer drug to reach a therapeutic concentration over time. The system is “reloadable” in that subsequent intravenous injections can be administered which will increase the intracranial concentration of the drug.
- Increases drug concentration delivered to the brain after systemic injection
- Enables lower systemic doses to be used – less side effects
- Only requires one intracranial injection but allows multiple anti-cancer drug deliveries
- Therapy of glioblastoma
- Therapy of other brain tumors, including metastasis from other primary tumors
Patrick CH Hsieh, David J. Lundy, Christopher Yu Tai Yen
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Optimization of reloadable hydrogel system for treating glioblastoma